Perikabiven
NDC 63323-714, Dextrose, Soybean oil, Electrolytes, Lysine, Phenylalanine, Leucine, Valine, Threonine, Methionine, Isoleucine, Tryptophan, Alanine, Arginine, Glycine, Proline, Histidine, Glutamic Acid, Serine, Aspartic Acid and Tyrosine, injection, emulsion, from Fresenius Kabi USA, LLC.
- Product NDC
- 63323-714
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, EMULSION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA200656
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63323-714 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXTROSE MONOHYDRATE7.5 g/100mL
- SOYBEAN OIL3.5 g/100mL
- SODIUM ACETATE170 mg/100mL
- POTASSIUM CHLORIDE124 mg/100mL
- SODIUM GLYCEROPHOSPHATE ANHYDROUS105 mg/100mL
- MAGNESIUM SULFATE HEPTAHYDRATE68 mg/100mL
- CALCIUM CHLORIDE20 mg/100mL
- LYSINE HYDROCHLORIDE187 mg/100mL
- PHENYLALANINE164 mg/100mL
- LEUCINE164 mg/100mL
- VALINE152 mg/100mL
- HISTIDINE141 mg/100mL
- THREONINE116 mg/100mL
- METHIONINE116 mg/100mL
- ISOLEUCINE116 mg/100mL
- TRYPTOPHAN40 mg/100mL
- ALANINE333 mg/100mL
- ARGININE235 mg/100mL
- GLYCINE164 mg/100mL
- PROLINE141 mg/100mL
- GLUTAMIC ACID116 mg/100mL
- SERINE94 mg/100mL
- ASPARTIC ACID71 mg/100mL
- TYROSINE4.8 mg/100mL
Pharmacologic classes
Amino Acid [EPC]; Amino Acids [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Lipid Emulsion [EPC]; Lipids [CS]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Potassium Compounds [CS]; Potassium Salt [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63323-714-14 | 63323071414 | 1440 mL in 1 BAG (63323-714-14) |
| 63323-714-19 | 63323071419 | 1920 mL in 1 BAG (63323-714-19) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/c2eb5522-8572-45f4-869d-42f9fd251bb6
Use it
Look up 63323-714 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63323-714 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63323-714. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.